Pharmaniaga to supply vaccines to private sector


However, the pharmaceutical group’s main priority is to supply the vaccines to the government first and then only channel the supply to the private sector, GLCs, expatriates and foreign workers, said its group managing director Datuk Zulkarnain Md Eusope.

KUALA LUMPUR: After winning the contract to supply millions of doses of CoronaVac, the Covid-19 vaccine developed by Sinovac Life Sciences of China, to the Health Ministry (MoH), Pharmaniaga Bhd is now also looking to supply the vaccines to the private sector and government-linked companies (GLCs) in the second half of the year.

However, the pharmaceutical group’s main priority is to supply the vaccines to the government first and then only channel the supply to the private sector, GLCs, expatriates and foreign workers, said its group managing director Datuk Zulkarnain Md Eusope.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Wall St set to open higher as Fed allays rate-hike concerns
Singapore DBS’s digital services hit days after MAS ban ends
US weekly jobless claims unchanged; layoffs decline in April
Gold falls as investors evaluate US rate cut prospects
UOA REIT expects office rental market to remain challenging
Ringgit rebounds to end higher vs US dollar
BHIC unit bags RMN submarine contract from Mindef worth RM43.6mil
Sapura Energy appoints Ganesh Gunaratnam as new CFO effective June 1
Capital A formulating regularisation plan to address PN17 status
Ajinomoto declares special dividend of RM2.12 from land sale

Others Also Read